⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29735361 | 1.00 | — | — | |
| Methane SCHEMBL7420104 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL30557202 | 0.97 | — | — | |
| SCHEMBL27957052 | 0.85 | APLNR (0.46) | — | |
| SCHEMBL27957064 | 0.80 | APLNR (0.42) | — | |
| SCHEMBL4974 | 0.78 | — | — | |
| SCHEMBL3819587 | 0.78 | — | — | |
| SCHEMBL28508474 | 0.76 | POLB (0.50) | — | |
| Hydrochloric Acid SCHEMBL28177242 | 0.76 | — | — | |
| SCHEMBL15650037 | 0.74 | FFAR1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025087337-A1 | DISSOCIATION AGENT AND KIT | 利多(香港)有限公司 | 2025-05-01 | — | — | WO | claimed |
| CN-119899825-A | Dissociating agent and kit | 利多(香港)有限公司 | 2025-04-29 | — | — | CN | claimed |
| WO-2024038357-A1 | SYNTHESIS OF SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS AND ANALOGUES THEREOF | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-02-22 | — | — | WO | claimed |
| CN-117169519-B | Dissociation agent and kit for detecting TT3 and/or TT4 in sample | 艾康生物技术(杭州)有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117169519-A | Dissociation agent and kit for detecting TT3 and/or TT4 in sample | 艾康生物技术(杭州)有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-114805192-B | Tricyclic XOR/URAT1 dual inhibitor containing 2-hydroxybenzoic acid and preparation method and application thereof | 华南理工大学 | 2023-05-23 | — | — | CN | claimed |
| CN-116003422-A | Synthesis method of 6-bromofuro [3,2-b ] pyridine-2-formaldehyde | 康化（上海）新药研发有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-114805192-A | Tricyclic XOR/URAT1 dual inhibitor containing 2-hydroxybenzoic acid and preparation method and application thereof | 华南理工大学 | 2022-07-29 | — | — | CN | claimed |
| CN-112362432-B | Dissociation agent universally used in serum TT3 and TT4 and preparation method thereof | 广州科方生物技术股份有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-112362432-A | Dissociation agent universally used in serum TT3 and TT4 and preparation method thereof | 广州科方生物技术股份有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-105461773-B | Preparation method and intermediate of sofosbuvir | 江苏豪森药业集团有限公司 | 2020-12-01 | — | — | CN | claimed |
| CN-105461774-B | Preparation method of sofosbuvir | 江苏豪森药业集团有限公司 | 2020-11-24 | — | — | CN | claimed |
| US-10619097-B2 | Low-[HF] room temperature wet chemical growth (RTWCG) chemical formulation | SPECMAT, INC. (US) | 2020-04-14 | — | — | US | claimed |
| CN-109942485-A | A kind of gram of azoles replaces the synthetic method of Buddhist nun's intermediate | 青岛前线生物工程有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-105461773-A | Preparation method and intermediate of sofosbuvir | JIANGSU HANSON PHAMA GROUP CO LTD | 2016-04-06 | — | — | CN | claimed |
| US-20150376498-A1 | LOW-[HF] ROOM TEMPERATURE WET CHEMICAL GROWTH (RTWCG) CHEMICAL FORMULATION | SPECMAT, INC. | 2015-12-31 | — | — | US | claimed |
| JP-7169091-A | — | — | None | — | — | JP | disclosed |
| EP-4747260-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-4192946-A | Process for producing 3-hydroxy-5-halopyridines | CIBA-GEIGY CORPORATION (US) | 1980-03-11 | — | — | US | disclosed |
| US-4192946-A | Process for producing 3-hydroxy-5-halopyridines | CIBA-GEIGY CORPORATION (US) | 1980-03-11 | — | — | US | disclosed |